Quantitative Investment Management LLC Has $2.85 Million Position in Varian Medical Systems (VAR)

Quantitative Investment Management LLC lowered its stake in shares of Varian Medical Systems (NYSE:VAR) by 78.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 25,600 shares of the medical equipment provider’s stock after selling 94,000 shares during the period. Quantitative Investment Management LLC’s holdings in Varian Medical Systems were worth $2,845,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of VAR. APG Asset Management N.V. lifted its stake in shares of Varian Medical Systems by 6.7% in the 4th quarter. APG Asset Management N.V. now owns 1,780,901 shares of the medical equipment provider’s stock valued at $164,846,000 after purchasing an additional 111,482 shares during the last quarter. Wells Fargo & Company MN lifted its stake in shares of Varian Medical Systems by 7.5% in the 4th quarter. Wells Fargo & Company MN now owns 1,205,836 shares of the medical equipment provider’s stock valued at $134,029,000 after purchasing an additional 83,772 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Varian Medical Systems by 4.2% in the 4th quarter. Geode Capital Management LLC now owns 1,186,042 shares of the medical equipment provider’s stock valued at $131,599,000 after purchasing an additional 47,590 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in shares of Varian Medical Systems by 15.9% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,134,054 shares of the medical equipment provider’s stock valued at $113,474,000 after purchasing an additional 155,954 shares during the last quarter. Finally, Ameriprise Financial Inc. lifted its stake in shares of Varian Medical Systems by 15.1% in the 3rd quarter. Ameriprise Financial Inc. now owns 816,983 shares of the medical equipment provider’s stock valued at $81,748,000 after purchasing an additional 106,899 shares during the last quarter. 99.21% of the stock is owned by institutional investors.

How to Become a New Pot Stock Millionaire

VAR has been the subject of several analyst reports. Citigroup lifted their price objective on shares of Varian Medical Systems from $128.00 to $132.00 and gave the company a “buy” rating in a research note on Thursday, January 25th. Zacks Investment Research raised shares of Varian Medical Systems from a “hold” rating to a “buy” rating and set a $142.00 price objective for the company in a research note on Tuesday, March 13th. ValuEngine raised shares of Varian Medical Systems from a “hold” rating to a “buy” rating in a research note on Thursday, March 1st. TheStreet lowered shares of Varian Medical Systems from a “b+” rating to a “c” rating in a research note on Monday, February 12th. Finally, BTIG Research reiterated a “hold” rating on shares of Varian Medical Systems in a report on Sunday, January 28th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $111.80.

In other news, SVP John W. Kuo sold 7,991 shares of the business’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $110.65, for a total transaction of $884,204.15. Following the transaction, the senior vice president now owns 27,363 shares in the company, valued at approximately $3,027,715.95. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director David J. Illingworth sold 5,651 shares of the business’s stock in a transaction dated Tuesday, March 6th. The stock was sold at an average price of $122.56, for a total transaction of $692,586.56. Following the transaction, the director now owns 12,737 shares in the company, valued at approximately $1,561,046.72. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 90,568 shares of company stock worth $10,905,313. Insiders own 0.78% of the company’s stock.

VAR traded down $2.83 during trading on Friday, hitting $117.64. The stock had a trading volume of 575,865 shares, compared to its average volume of 506,532. The company has a market capitalization of $10,740.53, a PE ratio of 32.68, a price-to-earnings-growth ratio of 3.41 and a beta of 0.82. Varian Medical Systems has a 12 month low of $87.49 and a 12 month high of $130.29.

Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings data on Wednesday, January 24th. The medical equipment provider reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.06. Varian Medical Systems had a net margin of 4.27% and a return on equity of 27.13%. The company had revenue of $678.50 million for the quarter, compared to the consensus estimate of $633.96 million. During the same quarter in the previous year, the firm posted $1.09 EPS. The business’s revenue was up 12.8% compared to the same quarter last year. equities research analysts forecast that Varian Medical Systems will post 4.31 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This news story was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/08/varian-medical-systems-inc-var-position-trimmed-by-quantitative-investment-management-llc.html.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Varian Particle Therapy. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply